A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stability.
about
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combination.Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocketPeptide fusion inhibitors targeting the HIV-1 gp41: a patent review (2009 - 2014).A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
P2860
A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stability.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel chimeric protein-based ...... th high potency and stability.
@ast
A novel chimeric protein-based ...... th high potency and stability.
@en
type
label
A novel chimeric protein-based ...... th high potency and stability.
@ast
A novel chimeric protein-based ...... th high potency and stability.
@en
prefLabel
A novel chimeric protein-based ...... th high potency and stability.
@ast
A novel chimeric protein-based ...... th high potency and stability.
@en
P2093
P2860
P356
P1476
A novel chimeric protein-based ...... th high potency and stability.
@en
P2093
P2860
P304
28425-28434
P356
10.1074/JBC.M111.241992
P407
P50
P577
2011-06-20T00:00:00Z